July 27, 2012 — To support research exploring childhood cancers, Elekta has given a €32,000 ($40,000) grant to Madrid Hospital Foundation’s pediatric oncology program at the Madrid Montepríncipe Hospital's pediatric oncology and hematology unit. The donation was collected at a charity party held in conjunction with the 2012 Annual Meeting of the European Society for Radiotherapy and Oncology (ESTRO) in Barcelona. The foundation’s pediatric oncology research programs focus on increasing the understanding of cancer in children, and on improving treatment methods and the patient’s quality of life.
“Because cancer occurs more often in adults than in children, most of today’s technological developments in radiation therapy focus on adult patients and their needs,” said Tomas Puusepp, president and CEO of Elekta. “To address this imbalance, we are pleased to support the efforts of worthy pediatric cancer research programs such as the foundation’s pediatric oncology program. Elekta’s own efforts are aimed at adapting radiation therapy treatments to children, such as developing more suitable immobilization devices and imaging strategies, and by studying how to adjust doses for pediatric patients. To that end, we recently created the Elekta Pediatric Research Group, whose mission is to identify, develop and adapt products to treat childhood cancer."
Elekta’s products are currently not approved for use on children.
For more information: www.elekta.com
April 10, 2026 
